title: Meeting report: The future of preclinical mouse models in melanoma treatment is now.
authors.affiliation: gmerlino@helix.nih.gov
authors.forename: Glenn
authors.initials: G
authors.lastname: Merlino
authors.forename: Keith
authors.initials: K
authors.lastname: Flaherty
authors.forename: Nicolas
authors.initials: N
authors.lastname: Acquavella
authors.forename: Chi-Ping
authors.initials: CP
authors.lastname: Day
authors.forename: Andrew
authors.initials: A
authors.lastname: Aplin
authors.forename: Sheri
authors.initials: S
authors.lastname: Holmen
authors.forename: Suzanne
authors.initials: S
authors.lastname: Topalian
authors.forename: Terry
authors.initials: T
authors.lastname: Van Dyke
authors.forename: Meenhard
authors.initials: M
authors.lastname: Herlyn
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D008495:Medical Oncology / Q000639:trends; D008545:Melanoma / Q000473:pathology* / Q000628:therapy*; D008546:Melanoma, Experimental / Q000473:pathology* / Q000628:therapy*; D051379:Mice; D009154:Mutation; D009368:Neoplasm Transplantation; D015143:Philadelphia; D012878:Skin Neoplasms / Q000473:pathology / Q000628:therapy